申请人:Concert Pharmaceuticals, Inc.
公开号:US10017445B2
公开(公告)日:2018-07-10
The present invention in one embodiment provides a compound of Formula I:(I), or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
本发明在一个实施方案中提供了式 I:(I)化合物或其药学上可接受的盐,其中式 I 中所示变量如说明书中所定义。